摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Chloro-3,6-dimethyl-6,11-dihydro-11-[(4-methylpiperazine-1-yl)-acetyl]-dibenzo[c,f][1,2,5]-thiadiazepine 5,5-dioxide | 128377-71-9

中文名称
——
中文别名
——
英文名称
2-Chloro-3,6-dimethyl-6,11-dihydro-11-[(4-methylpiperazine-1-yl)-acetyl]-dibenzo[c,f][1,2,5]-thiadiazepine 5,5-dioxide
英文别名
2-Chloro-3,6-dimethyl-6,11-dihydro-11-[(4-methylpiperazin-1-yl)-acetyl]-dibenzo [c,f][1,2,5]thiadiazepine 5,5-dioxide;1-(2-Chloro-3,6-dimethyl-5,5-dioxobenzo[c][1,2,5]benzothiadiazepin-11-yl)-2-(4-methylpiperazin-1-yl)ethanone
2-Chloro-3,6-dimethyl-6,11-dihydro-11-[(4-methylpiperazine-1-yl)-acetyl]-dibenzo[c,f][1,2,5]-thiadiazepine 5,5-dioxide化学式
CAS
128377-71-9
化学式
C21H25ClN4O3S
mdl
——
分子量
448.974
InChiKey
VWVNTUVHNMRIKZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    30
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    72.6
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    N-(2-bromophenyl)-4-chloro-5-methyl-2-aminobenzenesulfonamide 在 sodium methylatepotassium carbonate溶剂黄146 、 copper(I) bromide 作用下, 以 甲醇N,N-二甲基甲酰胺丙酮 为溶剂, 反应 36.0h, 生成 2-Chloro-3,6-dimethyl-6,11-dihydro-11-[(4-methylpiperazine-1-yl)-acetyl]-dibenzo[c,f][1,2,5]-thiadiazepine 5,5-dioxide
    参考文献:
    名称:
    New dibenzothiadiazepine derivatives with antidepressant activities
    摘要:
    A new series of 11-[(aminoalkyl)carbonyl] derivatives of 6,11-dihydrodibenzo[c,f][1,2,5]thiadiazepine 5,5-dioxide (10-39) were synthesized and evaluated for potential antidepressant activity in the apomorphine-induced hypothermia (Apo 16) test. Effects on reserpine-induced hypothermia and toxicity for the most potent antagonists of Apo 16 hypothermia were also studied. Structure-activity relationships are reported. Anticholinergic effects were evaluated for compound 12, identified as the most potent and least toxic in this series, by assessing physostigmine lethality. Compound 12 was also subjected to X-ray analysis.
    DOI:
    10.1021/jm00108a018
点击查看最新优质反应信息

文献信息

  • Novel derivatives of 6,11-dihydro-dibenzo(C,F)(1,2,5)-thiadiazepine
    申请人:A. Menarini Industrie Farmaceutiche Riunite
    公开号:US05011833A1
    公开(公告)日:1991-04-30
    Novel derivatives of 11-carbonyl-6,11-dihydrodibenzo[c,f][1,2,5]thiadiazepine 5,5-dioxide of the general formula ##STR1## wherein R and R.sub.1, which can be different, represent a hydrogen atom or a (C.sub.1 -C.sub.5) alkyl or (C.sub.1 -C.sub.4)hydroxyalkyl group, or R and R.sub.1 together can form a 5-membered and/or 6-membered heterocyclic ring which may contain a further heteroatom, R.sub.2 and R.sub.3, which can be different, represent a hydrogen atom, a (C.sub.1 -C.sub.3)alkoxy, (C.sub.1 -C.sub.3)alkyl, nitro, amino or (C.sub.1 -C.sub.3)alkylamino, halogen, halogeno-alkyl or hydroxyl group, R.sub.4 represents a hydrogen atom or a (C.sub.1 -C.sub.4) alkyl, alkylaryl or (C.sub.1 -C.sub.6)alkylamino group, and n assumes values of 0, 1 or 2, and non-toxic, pharmaceutically acceptable salts thereof, obtained by addition of acids or alkyl halides.
    11-酮基-6,11-二氢二苯并[c,f][1,2,5]噻二唑烷-5,5-二氧化物的新衍生物,其通式为##STR1##其中R和R.sub.1,可以是不同的,代表氢原子或(C.sub.1-C.sub.5)烷基或(C.sub.1-C.sub.4)羟基烷基,或者R和R.sub.1一起可以形成一个含有进一步杂原子的5-元和/或6-元杂环,R.sub.2和R.sub.3,可以是不同的,代表氢原子,(C.sub.1-C.sub.3) 烷氧基,(C.sub.1-C.sub.3) 烷基,硝基,氨基或(C.sub.1-C.sub.3) 烷基氨基,卤素,卤代烷基或羟基,R.sub.4代表氢原子或(C.sub.1-C.sub.4) 烷基,烷基芳基或(C.sub.1-C.sub.6) 烷基氨基,n取0、1或2的值,以及通过酸或烷基卤化物的加成获得的非毒性、药学上可接受的盐。
  • Novel derivatives of 6,11-dihydro-dibenzo[c,f][1,2,5]-thiadiazepine 5,5-dioxide, salts thereof and appropriate processes for the preparation thereof
    申请人:A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.
    公开号:EP0354885A1
    公开(公告)日:1990-02-14
    Novel derivatives of 11-carbonyl-6,11-dihydro-­dibenzo[c,f][1,2,5]thiadiazepine 5,5-dioxide of the general formula wherein R and R₁,      which can be different, represent a hydrogen atom or a (C₁-C₅)alkyl or (C₁-C₄)hydroxyalkyl group, or R and R₁ together can form a 5-­membered and/or 6-membered heterocyclic ring which may contain a further heteroatom, R₂ and R₃,      which can be different, represent a hydrogen atom, a (C₁-C₃)alkoxy, (C₁-C₃)alkyl, nitro, amino or (C₁-C₃)alkylamino,halogen, halogeno-alkyl or hydroxyl group, R₄      represents a hydrogen atom or a (C₁-C₄)alkyl, alkylaryl or (C₁-C₆)alkylamino group, and n      assumes values of 0, 1 or 2, and non-toxic, pharmaceutically acceptable salts, thereof, obtained by addition of acids of alkyl halides.
    11-酮基-6,11-二氢-二苯并[c,f][1,2,5]噻二氮杂环庚烷-5,5-二氧化物的新衍生物,通式如下,其中R和R₁(可以不同),代表氢原子或(C₁-C₅)烷基或(C₁-C₄)羟基烷基基团,或者R和R₁可共同形成含有进一步杂原子的5-或6-成员杂环环,R₂和R₃(可以不同),代表氢原子,(C₁-C₃)烷氧基,(C₁-C₃)烷基,硝基,氨基或(C₁-C₃)烷基氨基,卤素,卤代烷基或羟基基团,R₄代表氢原子或(C₁-C₄)烷基,烷基芳基或(C₁-C₆)烷基氨基基团,n取值为0、1或2,以及由烷基卤化物的酸添加得到的非毒性、药学上可接受的盐。
  • GIANNOTTI, DANILO;VITI, GIOVANNI;SBRACI, PIERO;PESTELLINI, VITTORIO;VOLTE+, J. MED. CHEM., 34,(1991) N, C. 1356-1362
    作者:GIANNOTTI, DANILO、VITI, GIOVANNI、SBRACI, PIERO、PESTELLINI, VITTORIO、VOLTE+
    DOI:——
    日期:——
  • US5011833A
    申请人:——
    公开号:US5011833A
    公开(公告)日:1991-04-30
  • New dibenzothiadiazepine derivatives with antidepressant activities
    作者:Danilo Giannotti、Giovanni Viti、Piero Sbraci、Vittorio Pestellini、Giovanna Volterra、Franco Borsini、Alessandro Lecci、Alberto Meli、Paolo Dapporto、Paola Paoli
    DOI:10.1021/jm00108a018
    日期:1991.4
    A new series of 11-[(aminoalkyl)carbonyl] derivatives of 6,11-dihydrodibenzo[c,f][1,2,5]thiadiazepine 5,5-dioxide (10-39) were synthesized and evaluated for potential antidepressant activity in the apomorphine-induced hypothermia (Apo 16) test. Effects on reserpine-induced hypothermia and toxicity for the most potent antagonists of Apo 16 hypothermia were also studied. Structure-activity relationships are reported. Anticholinergic effects were evaluated for compound 12, identified as the most potent and least toxic in this series, by assessing physostigmine lethality. Compound 12 was also subjected to X-ray analysis.
查看更多